cp wire

CP Wire Articles

Infant Bacterial Therapeutics Delays Ph III Start Date After Meeting with FDA
  • Trial expected to start in 1H2019
  • Improved protocol may allow for additional claims

Following its meeting with the US Food and Drug Administration (FDA) in Washington DC... read more

Sat, 11/24/18 - 11:06 am
Heat Biologics, Inc. Prices $12,000,000 Public Offering

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies with the goal of activating a patient's immune system against cancer through T-cell activation... read more

Wed, 11/21/18 - 10:24 am
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk


Cellanyx and clinical collaborators today reported results of a prostate cancer clinical study demonstrating the ability of the company’s live tumor cell phenotypic biomarker test to identify... read more

Wed, 11/21/18 - 10:06 am
LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
  • LEO Pharma is committed to$70 million comprised of equity financing and financial R&D support
  • PellePharm and its stockholders could receive up to an additional $690 million... read more
Tue, 11/20/18 - 09:56 am
PDUFA Date for Postpartum Depression Drug Delayed Three months
  • The new PDUFA date is March 19, 2019
  • The FDA has not requested any additional clinical data or any additional information from the Company as part of the extension


... read more

Tue, 11/20/18 - 09:23 am

Pages